AMICUS THERAPEUTICS, INC. — Director's Dealing 2014

Mar 12, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMICUS THERAPEUTICS INC (FOLD)
CIK: 0001178879
Period of Report: 2014-03-12

Reporting Person: LOVE TED W (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-03-12	Common Stock	A	110000	$2.21	Acquired	110000	Direct

Footnotes

F1: This price is the weighted average purchase price for the transactions reported on this line. The prices for the transactions reported on this line range from $2.11 to $2.24. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.